What Defines NK Cell Functional Fate: Phenotype or Metabolism?

by Sophie M. Poznanski, Ali A. Ashkar
Published 2019-06-01

Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes

by Emily Feng, Elizabeth Balint, Sophie M. Poznanski, Ali A. Ashkar, Mark Loeb
Published 2021-03-01

Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production

by Amanda J. Lee, Firoz Mian, Sophie M. Poznanski, Michele Stackaruk, Tiffany Chan, Marianne V. Chew, Ali A. Ashkar
Published 2019-06-01

Expanded human NK cells from lung cancer patients sensitize patients’ PDL1−negative tumors to PD1-blockade therapy

by Sophie M Poznanski, Tyrah M Ritchie, Isabella Y Fan, Abdullah El-Sayes, Ana L Portillo, Ronny Ben-Avi, Eduardo A Rojas, Marianne V Chew, Yaron Shargall, Ali A Ashkar
Published 2021-01-01

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors

by Ana L. Portillo, Richard Hogg, Sophie M. Poznanski, Eduardo A. Rojas, Niamh J. Cashell, Joanne A. Hammill, Marianne V. Chew, Mira M. Shenouda, Tyrah M. Ritchie, Quynh T. Cao, Jeremy A. Hirota, Sukhbinder Dhesy-Thind, Jonathan L. Bramson, Ali A. Ashkar
Published 2021-06-01